Ming-Mo Hou

1.5k total citations
9 papers, 129 citations indexed

About

Ming-Mo Hou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Ming-Mo Hou has authored 9 papers receiving a total of 129 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 2 papers in Surgery. Recurrent topics in Ming-Mo Hou's work include Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Mechanisms and Therapy (2 papers). Ming-Mo Hou is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (3 papers) and Cancer Mechanisms and Therapy (2 papers). Ming-Mo Hou collaborates with scholars based in Taiwan, United States and South Korea. Ming-Mo Hou's co-authors include Aung Naing, Siqing Fu, Filip Jankú, David S. Hong, Apostolia M. Tsimberidou, Ralph Zinner, Jennifer J. Wheler, Robert L. Coleman, Karen H. Lu and Xiaochun Liu and has published in prestigious journals such as Oncotarget, The Oncologist and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Ming-Mo Hou

8 papers receiving 127 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming-Mo Hou Taiwan 7 54 52 45 23 19 9 129
Xinyu Wu United States 5 27 0.5× 67 1.3× 39 0.9× 35 1.5× 49 2.6× 9 159
Justin Harold United States 8 30 0.6× 73 1.4× 48 1.1× 37 1.6× 16 0.8× 18 186
Jinyeong Lim South Korea 7 42 0.8× 37 0.7× 76 1.7× 46 2.0× 12 0.6× 18 157
Nikola Hájková Czechia 9 37 0.7× 69 1.3× 79 1.8× 37 1.6× 15 0.8× 25 194
Elizabeth V. Connor United States 6 21 0.4× 44 0.8× 53 1.2× 55 2.4× 26 1.4× 12 156
Erik Asmus United States 6 41 0.8× 100 1.9× 39 0.9× 36 1.6× 16 0.8× 9 179
Nicholas Hickson United Kingdom 8 57 1.1× 39 0.8× 66 1.5× 54 2.3× 16 0.8× 10 185
Ornella Nicoletto Italy 9 41 0.8× 69 1.3× 78 1.7× 35 1.5× 12 0.6× 15 180
Ian Lewis United Kingdom 6 23 0.4× 57 1.1× 50 1.1× 28 1.2× 19 1.0× 11 141

Countries citing papers authored by Ming-Mo Hou

Since Specialization
Citations

This map shows the geographic impact of Ming-Mo Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Mo Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Mo Hou more than expected).

Fields of papers citing papers by Ming-Mo Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming-Mo Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Mo Hou. The network helps show where Ming-Mo Hou may publish in the future.

Co-authorship network of co-authors of Ming-Mo Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Ming-Mo Hou. A scholar is included among the top collaborators of Ming-Mo Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming-Mo Hou. Ming-Mo Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Lin, Chia‐Chi, Toshihiko Doi, Kei Muro, et al.. (2021). Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in Asia. Targeted Oncology. 16(4). 447–459. 22 indexed citations
3.
Ho, Kung‐Chu, Yu-Hua Fang, Hsiao‐Wen Chung, et al.. (2016). TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib. European Journal of Nuclear Medicine and Molecular Imaging. 43(12). 2155–2165. 19 indexed citations
4.
Hou, Ming-Mo, Zhijie Wang, Filip Jankú, et al.. (2016). Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. Oncotarget. 7(23). 35132–35143. 9 indexed citations
5.
Fu, Siqing, Kirk S. Culotta, Gerald S. Falchook, et al.. (2015). Pharmacokinetic evaluation of nanoparticle albumin-bound paclitaxel delivered via hepatic arterial infusion in patients with predominantly hepatic metastases. Cancer Chemotherapy and Pharmacology. 77(2). 357–364. 6 indexed citations
6.
7.
Hou, Ming-Mo, Xiaochun Liu, Jennifer J. Wheler, et al.. (2014). Outcomes of patients with metastatic cervical cancer in a phase I clinical trials program.. PubMed. 34(5). 2349–55. 9 indexed citations
8.
Hou, Ming-Mo, Xiaochun Liu, Jennifer J. Wheler, et al.. (2014). Targeted PI3K/AKT/mTOR therapy for metastatic carcinomas of the cervix: A phase I clinical experience. Oncotarget. 5(22). 11168–11179. 50 indexed citations
9.
Hou, Ming-Mo, Han-Pin Kuo, Cheng‐Ta Yang, et al.. (2012). Erlotinib treatment in patients with advanced lung adenocarcinoma with CISH-positive and CISH-negative EGFR gene alterations.. PubMed. 32(3). 1107–12. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyu Wu Breakdown of academic impact, for papers by Justin Harold Breakdown of academic impact, for papers by Jinyeong Lim Breakdown of academic impact, for papers by Nikola Hájková Breakdown of academic impact, for papers by Elizabeth V. Connor Breakdown of academic impact, for papers by Erik Asmus Breakdown of academic impact, for papers by Nicholas Hickson Breakdown of academic impact, for papers by Ornella Nicoletto Breakdown of academic impact, for papers by Ian Lewis
Rankless by CCL
2026